PDS-0330

CAS No. 2904682-19-3

PDS-0330( —— )

Catalog No. M36554 CAS No. 2904682-19-3

PDS-0330 is a claudin-1 small molecule inhibitor inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 113 In Stock
10MG 187 In Stock
25MG 335 In Stock
50MG 477 In Stock
100MG 658 In Stock
200MG 886 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PDS-0330
  • Note
    Research use only, not for human use.
  • Brief Description
    PDS-0330 is a claudin-1 small molecule inhibitor inhibitor.
  • Description
    PDS-0330 is a specific and potent Claudin-1 inhibitor. PDS-0330 interferes with claudin-1/Src association and inhibits colorectal cancer (CRC) progression and metastasis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2904682-19-3
  • Formula Weight
    423.49
  • Molecular Formula
    C25H17N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 4 mg/mL (9.45 mM; Ultrasonic (<60°C)
  • SMILES
    N(C(NC(=O)C1=CC2=C(C=C1)C=CC=C2)=S)C3=CC=C(C4=NC=5C(O4)=CC=CC5)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fatima I, et al. Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis. Biomed Pharmacother. 2023 Mar;159:114255.?
molnova catalog
related products
  • NGR peptide Trifluor...

    NGR peptide Trifluoroacetate containing the asparagine-glycine-arginine (NGR) motif is recognized by CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in tumor neovasculature.

  • Orexin A (human, rat...

    Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.

  • Ingenol mebutate

    Ingenol mebutate is a potent activator of PKC subtypes including PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM.